Home
About
Overview
Sharing Data
ORCID
Help
History (1)
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. J Thorac Oncol. 2008 Nov; 3(11):1236-44.
View in:
PubMed
subject areas
Acetylation
Adenocarcinoma
Adipokines
Adult
Aged
Aged, 80 and over
Autoantibodies
Azacitidine
Biomarkers, Tumor
Carrier Proteins
Case-Control Studies
Enzyme Inhibitors
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Glycoproteins
Histone Acetyltransferases
Histone Deacetylase Inhibitors
Histone Deacetylases
Humans
Hydroxamic Acids
Immunoenzyme Techniques
Lung Neoplasms
Male
Middle Aged
Oligonucleotide Array Sequence Analysis
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Survival Rate
Tumor Cells, Cultured
authors with profiles
Christopher Seder